A Day Up For Kairos Pharma, Ltd.
Tue, Jul 15, 2025 at 07:15 PM
Kairos Pharma, Ltd. (KAPA:NYSEMKT) jumped higher at $1.17, representing a gain of 70.8%. On Tue, Jul 15, 2025, KAPA:NYSEMKT touched a New 2-Week High of $1.17. The stock got featured on our News Catalysts scanner on Tue, Jul 15, 2025 at 09:18 AM in the 'BIOTECH' category. From Tue, Jul 01, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Tue, Jul 15, 2025 at $1.82 with a volume of 241M+.
About Kairos Pharma, Ltd. (KAPA:NYSEMKT)
Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.
Top 10 Gainers:
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 272.51%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 160%
- Longevity Health Holdings, Inc. (XAGE:NASDAQ), 115.5%
- Kairos Pharma, Ltd. (KAPA:NYSEMKT), 70.78%
- Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 59.03%
- Polyrizon Ltd. (PLRZ:NASDAQ), 52.47%
- Rich Sparkle Holdings Limited (ANPA:NASDAQ), 50.66%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- Pitanium Limited (PTNM:NASDAQ), 46.98%
- Zepp Health Corporation (ZEPP:NYSE), 46.29%